Pieris Pharmaceuticals, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ACHL
Achilles Therapeutics plc |
$1.14 | $37.06 M | -0.56 | 204 | $0 |
ADAP
Adaptimmune Therapeutics plc |
$0.58 | $260.61 M | -1.4 | 449 | $60.28 M |
ADCT
ADC Therapeutics SA |
$2.01 | $329.09 M | -1.23 | 273 | $69.56 M |
AFMD
Affimed N.V. |
$1.24 | $93.50 M | -0.8 | 76 | $8.28 M |
AGEN
Agenus Inc. |
$2.75 | $348.59 M | 1.43 | 389 | $156.31 M |
CKPT
Checkpoint Therapeutics, Inc. |
$3.64 | $68.32 M | -0.72 | 23 | $103,000 |
CRVS
Corvus Pharmaceuticals, Inc. |
$4.90 | $126.98 M | -3.98 | 28 | $0 |
CUE
Cue Biopharma, Inc. |
$1.01 | $71.99 M | -1.38 | 53 | $5.49 M |
INZY
Inozyme Pharma, Inc. |
$2.93 | $286.39 M | -3.43 | 59 | $0 |
LPTX
Leap Therapeutics, Inc. |
$2.91 | $85.71 M | -1.79 | 54 | $0 |
MDNA
Medicenna Therapeutics Corp. |
$0.16 | $0 | -1.74 | 16 | $0 |
MREO
Mereo BioPharma Group plc |
$3.81 | $479.72 M | -22.8 | 33 | $10.00 M |
PDSB
PDS Biotechnology Corporation |
$1.64 | $106.92 M | -2.13 | 25 | $0 |
TCRR
TCR2 Therapeutics Inc. |
$1.48 | $58.11 M | -0.35 | 58 | $0 |
TERN
Terns Pharmaceuticals, Inc. |
$5.80 | $462.44 M | -5.67 | 66 | $0 |
XFOR
X4 Pharmaceuticals, Inc. |
$0.58 | $169.62 M | -1.51 | 127 | $0 |